The Enterprise Value as of December 2025 (TTM) for Cutia Therapeutics (2487.HK) is 1.85B

According to Cutia Therapeutics’s latest financial reports and current stock price. The company's current Enterprise Value is 1.85B. This represents a change of -18.19% compared to the average of 2.26B of the last 4 quarters.

Cutia Therapeutics (2487.HK) Historical Enterprise Value (quarterly & annually)

How has 2487.HK Enterprise Value performed in the past?

The mean historical Enterprise Value of Cutia Therapeutics over the last ten years is 1.68B. The current 1.85B Enterprise Value has changed 10.95% with respect to the historical average. Over the past ten years (40 quarters), 2487.HK's Enterprise Value was at its highest in in the June 2025 quarter at 3.00B. The Enterprise Value was at its lowest in in the June 2022 quarter at 0.

Cutia Therapeutics (2487.HK) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Cutia Therapeutics Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cutia Therapeutics (2487.HK) Average Enterprise Value

How has 2487.HK Enterprise Value performed in the past?

The current Enterprise Value of Cutia Therapeutics (2487.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Cutia Therapeutics (2487.HK) Enterprise Value vs. Peers

How is 2487.HK’s Enterprise Value compared to its peers?

Cutia Therapeutics’s Enterprise Value is greater than HighTide Therapeutics Inc (1.44B), greater than Frontage Holdings Corporation (372.33M), less than SinoMab BioScience Limited (1.96B), less than Clover Biopharmaceuticals, Ltd. (2.95B), less than Mabpharm Limited (2.42B), greater than Zhaoke Ophthalmology Limited (782.89M), greater than Shanghai Bio-heart Biological Technology Co., Ltd. (1.17B), greater than JW (Cayman) Therapeutics Co. Ltd (887.35M), less than Jiangsu Recbio Technology Co., Ltd. (3.12B), greater than Immunotech Biopharm Ltd (1.56B),

Build a custom stock screener for Cutia Therapeutics (2487.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cutia Therapeutics using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cutia Therapeutics (2487.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cutia Therapeutics or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.